Clinical associations of proinflammatory cytokines,oxidative biomarkers and vitamin D levels in systemic lupus erythematosus

Abstract

Background

The abnormal biological activity of cytokines plays an important role in the pathophysiology of both systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Several studies have highlighted the association of vitamin D and certain pro-inflammatory cytokines with disease activity in SLE. However, there are limited data on the association of vitamin D and antiphospholipid antibodies (aPL) with various proinflammatory biomarkers in these patients and their relative impact on clinical outcomes.

Methods

The serum levels of several aPL, 25-hydroxy-vitamin D, pro-inflammatory cytokines including IFNα, IL-1β, IL-6, IL-8, IP10, sCD40L, TNFα and VEGF were measured in 312 SLE patients from the Jamaican (n = 45) and Hopkins (n = 267) lupus cohorts using commercial Milliplex and ELISA assays. Oxidized LDL/β2glycoprotein antigenic complexes (oxLβ2Ag) and their associated antibodies were also measured in the Jamaican cohort. Healthy controls for oxidative marker and cytokine testing were used.

Results

Abnormally low vitamin D levels were present in 61.4% and 73.3% of Hopkins and Jamaican SLE patients, respectively. Median concentrations of IP10, TNFα, sCD40L and VEGF were elevated in both cohorts, oxLβ2Ag and IL-6 were elevated in the Jamaican cohort, and IFNα, IL-1β and IL-8 were the same or lower in both cohorts compared to controls. IP10 and VEGF were independent predictors of disease activity, aPL, IP10 and IL-6 were independent predictors of thrombosis and IL-8, and low vitamin D were independent predictors of pregnancy morbidity despite there being no association of vitamin D with pro-inflammatory cytokines.

Conclusions

Our results indicate that aPL-mediated pro-inflammatory cytokine production is likely a major mechanism of thrombus development in SLE patients. We provide presumptive evidence of the role IL-8 and hypovitaminosis D play in obstetric pathology in SLE but further studies are required to characterize the subtle complexities of vitamin D’s relationship with cytokine production and disease activity in these patients.

Keywords

Antiphospholipid syndrome cytokines oxidative biomarkers systemic lupus erythematosus thrombosis vitamin D

Get full access to this article

View all access options for this article.

References

Tunnicliffe

Singh-Grewal

Kim

Craig

Tong

. Diagnosis, monitoring, and treatment of systemic lupus erythematosus: A systematic review of clinical practice guidelines. Arthritis Care Res (Hoboken) 2015; 67: 1440–1452.

McClain

Arbuckle

Heinlen

et al.

The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004; 50: 1226–1232.

Bauer

Petri

Batliwalla

et al.

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. Arthritis Rheum 2009; 60: 3098–3107.

Davas

Tsirogianni

Kappou

Karamitsos

Economidou

Dantis

. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 1999; 18: 17–22.

Cuadrado

Buendía

Velasco

et al.

Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. J Thromb Haemost 2006; 4: 2461–2469.

Vega-Ostertag

Casper

Swerlick

Ferrara

Harris

Pierangeli

. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005; 52: 1545–1554.

Berman

Girardi

Salmon

. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 2005; 174: 485–490.

Cutolo

Otsa

. Review: Vitamin D, immunity and lupus. Lupus 2008; 17: 6–10.

Rhew

Dyer

et al.

25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 1387–1395.

10.

Amital

Szekanecz

Szücs

et al.

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?

Ann Rheum Dis 2010; 69: 1155–1157.

11.

Ruiz-Irastorza

Gordo

Olivares

Egurbide

Aguirre

. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010; 62: 1160–1165.

12.

Petri

Bello

Fang

Magder

. Vitamin D in systemic lupus erythematosus: Modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum 2013; 65: 1865–1871.

13.

Lima

Paupitz

Aikawa

Takayama

Bonfá

Pereira

. Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: A randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken) 2016; 68: 91–98.

14.

Piantoni

Andreoli

Allegri

Meroni

Tincani

. Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease. Reumatismo 2012; 64: 307–313.

15.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1–S266.

16.

Pierangeli

Harris

. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008; 3: 840–848.

17.

Willis

Seif

McGwin

Jr et al.

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: Data from LUMINA (LXXV), a multiethnic US cohort. Lupus 2012; 21: 830–835.

18.

Dawson-Hughes

Heaney

Holick

Lips

Meunier

Vieth

. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713–716.

19.

McGhie

DeCeulaer

Walters

Soyibo

Lee

. Vitamin D levels in Jamaican patients with systemic lupus erythematosus. Lupus 2014; 23: 1092–1096.

20.

Sahebari

Nabavi

Salehi

. Correlation between serum 25(OH)D values and lupus disease activity: An original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus 2014; 23: 1164–1177.

21.

Baechler

Batliwalla

Karypis

et al.

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610–2615.

22.

Linker-Israeli

Deans

Wallace

Prehn

Ozeri-Chen

Klinenberg

. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147: 117–123.

23.

Gabay

Cakir

Moral

et al.

Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997; 24: 303–308.

24.

Klarquist

Zhou

Shen

Janssen

. Dendritic cells in systemic lupus erythematosus: From pathogenic players to therapeutic tools. Mediators Inflamm 2016; 2016: 5045248–5045248.

25.

Camargo

Correa

Castiblanco

Anaya

. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004; 5: 609–614.

26.

Grenn

Yalavarthi

Gandhi

et al.

Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome. Ann Rheum Dis 2017; 76: 450–457.

27.

Kobayashi

Lopez

Matsuura

. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome. Ann N Y Acad Sci 2007; 1108: 489–496.

28.

Bolland

Grey

Avenell

Gamble

Reid

. Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040–d2040.

29.

Tosun

Celik

Avci

Yavuz

Alper

Malatyalioğlu

. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J Maternal Fetal Neonatal Med 2010; 23: 880–886.

30.

Azuma

Yamamoto

Chishima

. Effects of anti-beta2-GPI antibodies on cytokine production in normal first-trimester trophoblast cells. J Obstet Gynaecol Res 2016; 42: 769–775.

31.

Gysler

Mulla

Stuhlman

et al.

Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblast. Am J Reprod Immunol 2015; 73: 242–250.

32.

Ota

Dambaeva

Han

Beaman

Gilman-Sachs

Kwak-Kim

. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum Reprod 2014; 29: 208–219.

33.

Schneider

Colar da Silva

Werres Junior

et al.

Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus. Lupus 2015; 24: 1191–1197.